ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "T cells"

  • Abstract Number: 717 • 2013 ACR/ARHP Annual Meeting

    Patients With Rheumatoid Arthritis Have Impaired Candida Albicans Specific Th17 Responses But Preserved Oral Candida Albicans Protective Immunity

    Shrinivas Bishu1, E. Wern Su2, Erich Wikerson3, Donald M. Jones4, Kelly A. Reckley5, Sarah L. Gaffen3 and Marc C. Levesque6, 1Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA, 2Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 3Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 5Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 6Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA

    Background/Purpose: Rheumatoid arthritis (RA) patients are susceptible to infections, even after controlling for the effects of medications.  Recent data suggest an important role for the…
  • Abstract Number: 39 • 2013 ACR/ARHP Annual Meeting

    Chaperone-Mediated Autophagy As a Target Of Therapeutic P140 Peptide Used In Lupus

    Sylviane Muller, Institut de Biologie Moléculaire et Cellulaire, CNRS, Strasbourg, France

    Background/Purpose: In the pipeline of molecules with a potential for treating lupus patients, the P140 peptide/Lupuzor holds a lot of promise. P140 is a 21-mer…
  • Abstract Number: 2712 • 2013 ACR/ARHP Annual Meeting

    Increased Soluble PD-1: A Link Between Generation Of Immunological Memory and Risk Of Disease Flare In Early RA

    Stinne Greisen1, Tue W. Kragstrup2, Kristian Stengaard-Pedersen3, Merete Lund Hetland4, Kim Hørslev-Petersen5, Malene Hvid6 and Bent Deleuran2, 1Dept of Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Biomedicine, Aarhus University, Aarhus, Denmark, 3Arhus University Hospital, Aarhus, Denmark, 4Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, The Danish Rheumatologic Database (DANBIO), Glostrup Hospital., Copenhagen, Denmark, 5Institute of Regional Health Services Research, University of Southern Denmark, Graasten, Denmark, 6Dept. of Clinical Medicine, Aarhus University, Aarhus, Denmark

    Background/Purpose: Disturbances in the regulatory mechanisms of the immune system play a major role in rheumatoid arthritis (RA). Programmed Death 1 (PD-1) on lymphocytes negatively…
  • Abstract Number: 1654 • 2013 ACR/ARHP Annual Meeting

    Characterization Of T Cell Phenotype and Function In a Double Transgenic (Collagen-Specific TCR /HLA-DR1) Humanized Model Of Arthritis

    Seunghyun Kim1, Bo Tang2, Sarah Hammond3, DL Cullins3, David Brand4, EF Rosloniec3, John M. Stuart5, Arnold E. Postlethwaite6, AH Kang3 and Linda Myers3, 1Medicine/Rheumatology, University of Tennessee Health Science Center, Memphis, TN, 2Immunology, St. Jude Children's Research Hospital, Memphis, TN, 3University of Tennessee Health Science Center, Memphis, TN, 4Research Service 151, VA Medical Center, Memphis, TN, 5Medicine, VA Medical Center, University of Tennessee Health Science Center, Memphis, TN, 6Med-Div of Conn Tis Dis, University of Tennessee Health Science Center, Memphis, TN

    Background/Purpose: T cells orchestrate joint inflammation in rheumatoid arthritis (RA), yet they are difficult to study due to the small numbers of antigen-specific cells. The…
  • Abstract Number: 718 • 2013 ACR/ARHP Annual Meeting

    Mesenchymal Stem Cells and Skin Fibroblasts Both Suppress Early Steps In T Cell Activation In a Nitric-Oxide Dependent Manner

    Runsheng Wang1, Francoise Meylan2, Jizhong Zou3, Mahendra Rao3 and Richard M. Siegel4, 1NIH/NIAMS, Rheumatology fellowship and training branch, Bethesda, MD, 2NIH/NIAMS, autoimmunity branch, Bethesda, MD, 3NIH/NIAMS, center for regenerative medicine, Bethesda, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose: Mesenchymal stem cells (MSCs) are multipotent cells with capacity to differentiate into osteoblasts, chondrocytes, and adipocytes.  A phase II study in Europe has shown…
  • Abstract Number: 2714 • 2013 ACR/ARHP Annual Meeting

    Commensal Intestinal Microbiota Drives Spontaneous Interleukin-1- and T Helper 17-Mediated Arthritis In Mice

    Shahla Abdollahi-Roodsaz1, Rebecca Rogier2, Tom Ederveen2, Harm Wopereis3, Raish Oozeer3, Marije I. Koenders2 and Wim B. van den Berg1, 1Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands, 3Danone Research, Wageningen, Netherlands

    Background/Purpose: Altered composition of intestinal microbiota in recent-onset rheumatoid arthritis (RA) and possible efficacy of oral antibiotics suggest a role of intestinal microbiota in RA.…
  • Abstract Number: 1656 • 2013 ACR/ARHP Annual Meeting

    Interferon Type I and T Helper 17: A Dangerous Liaison In Primary Sjögren’s Syndrome?

    Zana Brkic1, Sandra M.J. Paulissen2, Cornelia G. van Helden-Meeuwsen3, Naomi I. Maria3, Odilia B.J. Corneth4, Nadine Davelaar5, Jan Piet van Hamburg5, Paul L. Van Daele3, Virgil A. Dalm1, Martin van Hagen3, Erik Lubberts6 and Marjan A. Versnel1, 1Erasmus Medical Center, Immunology, Rotterdam, Netherlands, 2Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, 3Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 4Rheumatology and Immunology, Erasmus Medical Center, Rotterdam, Netherlands, 5Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 6Erasmus Medical Center, Rheumatology, Rotterdam, Netherlands

    Background/Purpose: The T helper 17 (Th17) cell subset, which produces IL-17A, IL-17F, IL-22 and IL-21, has been implicated in the pathogenesis of primary Sjögren’s syndrome…
  • Abstract Number: 719 • 2013 ACR/ARHP Annual Meeting

    Mammalian Target Of Rapamycin (mTOR) Skews T Cell Lineage Development In Systemic Lupus Erythematosus (SLE)

    Hiroshi Kato1 and Andras Perl2, 1Internal Medicine, Division of Rheumatology, SUNY Upstate Medical University, Syracuse, NY, 2Dept of Medicine, SUNY Upstate Medical University, Syracuse, NY

    Background/Purpose: mTOR activity is increased in SLE T cells and its blockade has therapeutic efficacy in SLE. Murine studies showed essential roles of mTORC1 in…
  • Abstract Number: 2328 • 2012 ACR/ARHP Annual Meeting

    A Novel Method for Quantitative and Functional Analysis of Autophagy Using Flow Cytometry in Activated Human Primary T Cells

    Ryu Watanabe1, Hiroshi Fujii2, Yukiko Kamogawa2, Kyohei Nakamura1, Tsuyoshi Shirai2, Yumi Tajima2, Shinichiro Saito2, Tomonori Ishii1 and Hideo Harigae1, 1Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, 2Tohoku University, Sendai, Japan

    Background/Purpose: Autophagy is an evolutionally conserved self-degradation system. In this process, an isolation membrane engulfs cytoplasmic materials and organelles to form an autophagosome. The autophagosome…
  • Abstract Number: 2315 • 2012 ACR/ARHP Annual Meeting

    Foxp3+ Treg Cells Decreased in Overexpression of T-Bet in PD-1 Deficient Mice

    Masahiro Tahara1, Yuya Kondo1, Hiroto Tsuboi2, Satoru Takahashi3, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 3Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba city, Ibaraki, Japan

    Background/Purpose: Programmed cell Death-1 (PD-1) plays an important role in peripheral T cell tolerance, therefore PD-1 deficient (PD-1 KO) mice develop strain-specific autoimmune phenotypes. C57BL/6…
  • Abstract Number: 1513 • 2012 ACR/ARHP Annual Meeting

    TSLP Receptor Deficiency Reduces IL-13 Expression and Prevents Fibrosis in Experimental Scleroderma

    Alicia Usategui1, Vanessa Miranda1, Gabriel Criado2, Manuel J. Del Rey1, Elena Izquierdo1, Warren J. Leonard3 and Jose L. Pablos1, 1Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 2Grupo de Enfermedades Inflamatorias y Autoinmunes, Instituto de Investigación Hospital 12 de Octubre (I+12), Madrid, Spain, 3Laboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive fibrosis of the skin and internal organs. Although SSc shares pathogenetic features with other…
  • Abstract Number: 518 • 2012 ACR/ARHP Annual Meeting

    Spontaneous Sialadenitis Like Sjögren’s Syndrome in Orphan Nuclear Receptor γt (RORγt) Transgenic Mice

    Mana Iizuka1, Hiroto Tsuboi1, Hiromitsu Asashima1, Yuya Kondo1, Satoru Takahashi2, Isao Matsumoto1 and Takayuki Sumida1, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 2Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: The nuclear receptors retinoic-acid-receptor-related orphan receptors gt (RORγt) is required for the generation of Th17 cells expressing the proinflammatory cytokine IL-17. Th17 cells expressing…
  • Abstract Number: 2330 • 2012 ACR/ARHP Annual Meeting

    Mucosal-Associated Invariant T Cells Are Inactivated by IFNα and Reduced in Systemic Lupus Erythematosus

    Asako Chiba1, Naoto Tamura2, Ran Matsudaira3, Takashi Yamamura1, Yoshinari Takasaki2 and Sachiko Miyake1, 1Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan, 2Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 3Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan

    Background/Purpose: Mucosal-associated invariant T (MAIT) cells are a subset of innate-like lymphocytes which are restricted by the MHC-related molecule-1 (MR1) and express an invariant TCRα…
  • Abstract Number: 2317 • 2012 ACR/ARHP Annual Meeting

    Protein Phosphatase 5 (PP5) Regulates Methylation Sensitive Gene Expression in CD4+ T Cells

    Dipak R. Patel, Gabriela Gorelik and Bruce C. Richardson, Internal Medicine, University of Michigan, Ann Arbor, MI

    Background/Purpose: CD4+CD28- T cells are enriched in chronic inflammatory diseases like rheumatoid arthritis (RA) and lupus.  They are cytotoxic and resistant to apoptosis.  Compared to…
  • Abstract Number: 1442 • 2012 ACR/ARHP Annual Meeting

    IRF-1 Deficient Lupus-Prone MRL/Lpr Mice Show Reduced Glomerulonephritis but Develop Severe Interstitial Nephritis, Renal Vasculitis and Pulmonary Granulomas with Propensity for Th2 Polarity

    Hidemaru Sekine1, Takeshi Machida1, Natsumi Sakamoto1, Eiji Suzuki2, Xian Zhang3, Christopher Reilly4 and Gary S. Gilkeson5, 1Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan, 2Medicine, Medical University of South Carolina, Charleston, SC, 3Medicine, Medical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, SC, 4Virginia Tech, Blacksburg, VA, 5Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: The transcription factor interferon regulatory factor-4 (IRF-4) and -1 (IRF-1) are members of the IRF family of transcription regulators and involved in the development…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 32
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology